Neuroleptic Malignant Syndrome Secondary to Olanzapine Use

被引：0
|
作者：
Arumairaj, A. J. [1 ]
Vista, M. [1 ]
Chaudhari, A. [2 ]
Lee, S. [2 ]
Newman, T. [3 ]
机构：
[1] Metropolitan Hosp Ctr, Internal Med, New York, NY 10029 USA
[2] Metropolitan Hosp Ctr, Div Nephrol, Internal Med, New York, NY 10029 USA
[3] Metropolitan Hosp Ctr, Div Pulm Crit Care, Internal Med, New York, NY 10029 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3497
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Possible neuroleptic malignant syndrome associated with olanzapine
    Nyfort-Hansen, K
    Alderman, CP
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (05) : 667 - 667
  • [22] Olanzapine-associated neuroleptic malignant syndrome
    Kontaxakis, VP
    Havaki-Kontaxaki, BJ
    Christodoulou, NG
    Paplos, KG
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (05): : 897 - 902
  • [23] Olanzapine induced "typical" neuroleptic malignant syndrome
    Goveas, JS
    Hermida, A
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (01) : 101 - 102
  • [24] Olanzapine-associated neuroleptic malignant syndrome
    Norgard, Nick B.
    Stark, Jennifer E.
    PHARMACOTHERAPY, 2006, 26 (08): : 1180 - 1182
  • [25] Neuroleptic malignant syndrome as a consequence of the use of low dose olanzapine: a matter to consider
    Inca Torres, K.
    Renau Minguez, B.
    Juanes, A.
    Cruz Fourcade, J. F.
    Alvarez-Sesmero, S.
    Losada, C.
    EUROPEAN PSYCHIATRY, 2020, 63 : S485 - S485
  • [26] OLANZAPINE INDUCED NEUROLEPTIC MALIGNANT SYNDROME IN AN ICU PATIENT
    Willett, Kristine
    Durand, Cherlyl
    Sanford, Mary
    CRITICAL CARE MEDICINE, 2009, 37 (12) : A533 - A533
  • [27] Atypical neuroleptic malignant syndrome caused by olanzapine - comment
    Abad, JMH
    ACTA PSYCHIATRICA SCANDINAVICA, 2005, 112 (03) : 240 - 240
  • [28] Neuroleptic malignant syndrome and low-dose olanzapine
    Suh, H
    Bronson, B
    Martin, R
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (04): : 796 - 796
  • [29] Olanzapine induced neuroleptic malignant syndrome - a case review
    Kogoj, A
    Velikonja, I
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2003, 18 (04) : 301 - 309
  • [30] Life threatening neuroleptic malignant syndrome due to olanzapine
    Kopf, A
    Köster, J
    Schulz, A
    Krömker, H
    Becker, T
    PSYCHIATRISCHE PRAXIS, 2003, 30 (05) : 279 - 282
12345